KDV B — Kdventures AB Share News
0.000.00%
Last trade - 00:00- SEK185.53m
- SEK138.12m
- SEK1.67m
Brief: Karolinska Development's Modus Therapeutics Gets Approval For 2nd Part Of Phase 2 Study
Brief: Karolinska Development Announces Boost Pharma's New Long-Term Data
Brief: Karolinska Development Invests SEK 7.5 Million In Boost Pharma
Brief: Karolinska Development's Dilafor Gets Patent In US
Brief: Karolinska Development Portfolio Co Publishes Data On Golexanolone
Brief: Karolinska Development Q2 Net Loss At SEK 73.3 Mln
Brief: Karolinska Development Says Modus Therapeutics Raises SEK 28.3 Mln
Brief: Karolinska Development's Portfolio Company Umecrine Cognition Raises MSEK 24.6 For The Ongoing Clinical Development Of Golexanolone
Brief: Karolinska Development Gets Update From Organon Concerning OG-6219
Brief: Karolinska Development Divests Shares In Portfolio Company Ossdsign
Brief: Karolinska Development Modus Therapeutics Carries Out Rights Issue
Brief: Karolinska Development Q1 Net Income SEK -14.2 Million
Brief: Pharmnovo Receives Positive FDA Feedback On Drug Candidate PN6047
Brief: Karolinska Development Q4 Net Profit SEK 18.6 Million
Brief: Karolinska Development Q4 Net Income SEK -18.6 Million
Brief: Karolinska Development's Portfolio Company Raises SEK 205 Million
Brief: Karolinska Development's Portfolio Company Raises SEK 23.8 Mln To Continue Development Of Golexanolone
Brief: Ben Toogood Appointed As Chairman Of Karolinska Development
Brief: Karolinska Development Chairman Hans Wigzell Resigns